MARA 2016

For more information on the program and speakers or to register, please visit the event website at: 

Looking forward to meeting you there!


David and Goliath in the female incontinence mesh battle!

The company, along with other medical device makers, have been hit with series of lawsuits related to transvaginal meshes, intended to treat pelvic organ prolapse. Last July, Endo settled a batch of product liability lawsuits brought against subsidiary American Medical Systems Holdings over its pelvic mesh implants.

The FDA, prompted by a significant increase in complaints about a type of surgical mesh used to treat pelvic organ prolapse in women, put the products under its most stringent level of review, Class III, in January.

CL Medical with their I-STOP female incontinence mesh supported by strong clinical evidence, is proving, not only the efficiency of the product, but also its quality. With this product of such high standard, the manufacturer is positioned to take advantage in the market. Indeed, with several players removing themselves from the market, CL Medical could become a dominant player in the incontinence field. 

LOK Corporation is proud to be their partner as international manufacturer agent.

For more information on the products and explore the opportunity for your market, please contact our manufacturer agent department at 


LOK Corporation International Ltd. signs exclusive Territory management agreement with LIDCO Group.

London, February 16th 2016 – LOK Corporation International Ltd. has signed an exclusive territory management agreement between their Alliance Medical division and the UK based hemodynamic monitoring company LIDCO (AIM:LID).

 Alliance Medical is committed to promote exclusively all LIDCO products by taking responsibility for the distribution management, regulatory compliance support and marketing activities for the Canadian and South African markets.

« We are very excited to associate ourselves with a well-established Company like LIDCO, we are convinced that Alliance Medical Canada and Alliance Medical South Africa will contribute to expand the brand recognition of LIDCO in these markets » said Daniel Cloutier CEO for LOK Corporation International Ltd.


LIDCO is a supplier of minimally invasive hemodynamic equipment for hospitals, to monitor the amount of blood flowing around the body and ensure that vital organs are adequately perfused and oxygenated.

LIDCO’s technology, developed at St Thomas’ Hospital in London, has been shown to significantly reduce morbidity & complications, length of stay and overall costs associated with major surgery. 

About LOK Corporation International Ltd.

The Company operated under two main divisions; LOK Network providing regulatory compliance services and manufacturer agent services with 12 offices worldwide and Alliance Medical providing territory management services with branches in Canada, Russia & EEU, GCC, South Africa and India & SAARC.